Is Lifecore Biomedical (LFCR) an Asymmetric Risk-Reward in Pharma Contract Manufacturing?
Diranko Capital, an independent investment management firm, released its Q3 2026 investor letter. The letter can be downloaded here.
Lifecore Biomedical Inc. (LFCR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Greenhaven Road Investment Management Scott Stewart Miller | 2,868,881 | $18,877,237 | -11% | 14.57% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 259,144 | $1,705,167 | +47% | 0% |
| 3. | Renaissance Technologies Jim Simons | 163,000 | $1,072,540 | +56% | 0% |
| 4. | GAMCO Investors Mario Gabelli | 83,800 | $551,404 | 0.01% | |
| 5. | Squarepoint Ops LLC Maxime Fortin (Cio) | 23,275 | $153,150 | -75% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.74 | 17,000 | $97,580.00 | 559,717 | 2025-01-08 | Filing | |
| $4.10 | 169,753 | $695,987.30 | 2,607,433 | 2024-10-03 | Filing | |
| $4.10 | 122,930 | $504,013.00 | 2,095,783 | 2024-10-03 | Filing | |
| $4.10 | 152,102 | $623,618.20 | 319,286 | 2024-10-03 | Filing | |
| $4.10 | 1,311,312 | $5,376,379.20 | 4,084,268 | 2024-10-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.12 | 150,419 | $1,071,554.87 | 264,180 | 2025-05-28 | Filing | |
| $6.50 | 1,139,504 | $7,411,561.92 | 414,599 | 2025-05-27 | Filing | |
| $6.75 | 96,137 | $649,386.21 | 1,554,103 | 2025-05-23 | Filing | |
| $7.00 | 12,334 | $86,352.80 | 1,650,240 | 2025-05-13 | Filing | |
| $7.03 | 45,698 | $321,426.02 | 1,662,574 | 2025-05-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 848,624 | $5,585,482 | 0% | |
| 2. | 638,081 | $4,198,573 | 0% | |
| 3. | 539,450 | $3,549,581 | 0.19% | |
| 4. | 376,500 | $2,477,370 | 0.56% | |
| 5. | 267,300 | $1,758,834 | 0% |
News See All
Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market
Laughing Water Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations?
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Lifecore Biomedical, Inc. (NASDAQ:LFCR) is one of the best low-priced pharma stocks on this list.
12 Best Low-Priced Pharma Stocks to Buy Right Now
In this article, we will be taking a look at the 12 Best Low-Priced Pharma Stocks to Buy Right Now.
Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
What Contributes to Lifecore Biomedical's (LFCR) Distinct Competitive Advantage?
Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter.
Here’s the Analysis of LifeCore’s (LFCR) Growth Potential
Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3
Laughing Water Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Does LifeCore (LFCR) Have a High Expected Value?
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here.
Hedge Fund Resource Center